litlas
Log inCreate account

Daniel Olive

Active 1986–2025

139
Papers
18,407
Citations
83
h-index
132
i10-index

Citations

Citations per year for Daniel Olive1986: 1 citations1987: 5 citations1988: 14 citations1989: 35 citations1990: 35 citations1991: 33 citations1992: 23 citations1993: 20 citations1994: 18 citations1995: 35 citations1996: 44 citations1997: 24 citations1998: 41 citations1999: 32 citations2000: 50 citations2001: 69 citations2002: 63 citations2003: 65 citations2004: 63 citations2005: 67 citations2006: 55 citations2007: 65 citations2008: 70 citations2009: 93 citations2010: 106 citations2011: 119 citations2012: 151 citations2013: 182 citations2014: 168 citations2015: 190 citations2016: 167 citations2017: 230 citations2018: 222 citations2019: 661 citations2020: 841 citations2021: 871 citations2022: 653 citations2023: 536 citations2024: 786 citations2025: 384 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,186 citing papers, 25% of this breakdownChina: 1,108 citing papers, 12.7% of this breakdownFrance: 651 citing papers, 7.5% of this breakdownItaly: 521 citing papers, 6% of this breakdownGermany: 501 citing papers, 5.7% of this breakdownUnited Kingdom: 452 citing papers, 5.2% of this breakdownSpain: 243 citing papers, 2.8% of this breakdownCanada: 242 citing papers, 2.8% of this breakdownJapan: 240 citing papers, 2.7% of this breakdownAustralia: 225 citing papers, 2.6% of this breakdownNetherlands: 214 citing papers, 2.4% of this breakdownSwitzerland: 174 citing papers, 2% of this breakdown
0%25%Other 22.6%

Institutions

Fields

  • Medicine44.3%
  • Immunology and Microbiology41.5%
  • Biochemistry, Genetics and Molecular Biology11%
  • Engineering1.2%
  • Neuroscience0.9%
  • Agricultural and Biological Sciences0.3%
  • Other0.8%

Topics

  • Immune Cell Function and Interaction14.8%
  • Cancer Immunotherapy and Biomarkers9.4%
  • T-cell and B-cell Immunology8%
  • Immunotherapy and Immune Responses7.1%
  • CAR-T cell therapy research6.5%
  • Immune cells in cancer3.5%
  • Other50.7%

Coauthors

All papers

Open in search
  1. Major pathways involved in macrophage polarization in cancer

    Authors: Clément Kerneur, Carla E. Cano, Daniel Olive - Frontiers in Immunology 2022 cited by 341

  2. Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing

    Authors: Sumin Jo, Shipra Das, Alan F. Williams, Anne-Sophie Chrétien, Thomas Pagliardini, Aude Le Roy, Jorge Postigo, Diane Le Clerre, Billal Jahangiri, Isabelle Chion-Sotinel, Sandra Rozlan, Emilie Dessez, Agnès Gouble, Mathilde Dusséaux, Román Galetto, Aymeric Duclert, Emanuela Marcenaro, Raynier Devillier, Daniel Olive, Philippe Duchâteau, Laurent Poirot, Julien Valton - Nature Communications 2022 cited by 154

  3. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

    Authors: Émilie Mamessier, Aude Sylvain, Marie‐Laure Thibult, Gilles Houvenaeghel, Jocelyne Jacquemier, Rémy Castellano, Anthony Gonçalvès, Pascale André, François Romagné, Gilles Thibault, Patrice Viens, Daniel Birnbaum, François Bertucci, Alessandro Moretta, Daniel Olive - Journal of Clinical Investigation 2011 cited by 676

  4. Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization

    Authors: Silvia Pesce, Marco Greppi, Giovanna Tabellini, Fabio Rampinelli, Silvia Parolini, Daniel Olive, Lorenzo Moretta, Alessandro Moretta, Emanuela Marcenaro - Journal of Allergy and Clinical Immunology 2016 cited by 446

  5. Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome

    Authors: Michael Gobert, Isabelle Treilleux, Nathalie Bendriss‐Vermare, Thomas Bachelot, Sophie Goddard‐Léon, Vanessa Arfi, Cathy Biota, Anne Claire Doffin, Isabelle Durand, Daniel Olive, Solène Perez, Nicolas Pasqual, Christelle Fauré, Isabelle Ray‐Coquard, Alain Puisieux, Christophe Caux, Jean‐Yves Blay, Christine Ménétrier‐Caux - Cancer Research 2009 cited by 744

  6. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

    Authors: Christelle Harly, Yves Claude Guillaume, Steven Nédellec, Cassie-Marie Peigné, Hannu Mönkkönen, Jukka Mönkkönen, Jianqiang Li, Jürgen Kuball, Erin J. Adams, Sonia Netzer, Julie Déchanet‐Merville, Alexandra Léger, Thomas Herrmann, Richard Breathnach, Daniel Olive, Marc Bonneville, Emmanuel Scotet - Blood 2012 cited by 525

  7. 3D Tumor Models and Their Use for the Testing of Immunotherapies

    Authors: Nicolas Boucherit, Laurent Gorvel, Daniel Olive - Frontiers in Immunology 2020 cited by 169

  8. PD-1 is a novel regulator of human B-cell activation

    Authors: Marie‐Laure Thibult, Émilie Mamessier, Julie Gertner-Dardenne, Sonia Pastor, Sylvaine Just‐Landi, Luc Xerri, Bruno Chetaille, Daniel Olive - International Immunology 2012 cited by 360

  9. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC

    Authors: Priyanka Devi-Marulkar, Solène Fastenackels, Pierre Karapentiantz, Jérémy Goc, Claire Germain, Hélène Kaplon, Samantha Knockaert, Daniel Olive, Marylou Panouillot, Pierre Validire, Diane Damotte, Marco Alifano, Juliette Murris, Sandrine Katsahian, Myriam Lawand, Marie‐Caroline Dieu‐Nosjean - Communications Biology 2022 cited by 81

  10. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

    Authors: M. Mrabet, Olivier Cabaud, Emmanuelle Josselin, Pascal Finetti, Ronald K. Castellano, Anne Farina, E. Agavnian-Couquiaud, G. Saviane, Yves Collette, Patrice Viens, Ana Sofia Gonçalves, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Daniel Birnbaum, Daniel Olive, François Bertucci, Marc Lopez - Annals of Oncology 2016 cited by 172

  11. Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response

    Authors: Aude De Gassart, Kieu-Suong Le, Patrick Brune, Sophie Agaugué, Jennifer S. Sims, Armelle Goubard, Rémy Castellano, Noémie Joalland, Emmanuel Scotet, Yves Collette, Emmanuel Valentin, Clément Ghigo, Christine L. Pasero, Magali Colazet, Jaime Guillén, Carla E. Cano, Aurélien Marabelle, Johann S. de Bono, René Hoet, Alemseged Truneh, Daniel Olive, Paul Frohna - Science Translational Medicine 2021 cited by 106

  12. Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity

    Authors: P Bernard, Rebecca B. Delconte, Sonia Pastor, Vladimir Laletin, Cathy Costa Da Silva, Armelle Goubard, Emmanuelle Josselin, Rémy Castellano, Adrien Krug, Julien Vernerey, Raynier Devillier, Daniel Olive, Els Verhoeyen, Éric Vivier, Nicholas D. Huntington, Jacques A. Nunès, Geoffrey Guittard - Journal for ImmunoTherapy of Cancer 2022 cited by 68

  13. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma

    Authors: Asma Beldi‐Ferchiou, Marion Lambert, Stéphanie Dogniaux, Fréderic Vély, Éric Vivier, Daniel Olive, Stéphanie Dupuy, Franck Levasseur, D. Zucman, Célèste Lebbé, D. Sène, Claire Hivroz, Sophie Caillat‐Zucman - Oncotarget 2016 cited by 293

  14. T lymphocyte subsets in cancer immunity: Friends or foes

    Authors: Dounia Chraa, Asmâa Naim, Daniel Olive, Abdallah Badou - Journal of Leukocyte Biology 2018 cited by 164

  15. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells

    Authors: Carla E. Cano, Christine L. Pasero, Aude De Gassart, Clément Kerneur, Mélanie Gabriac, Marie Fullana, Emilie Granarolo, René Hoet, Emmanuel Scotet, Chirine Rafia, Thomas Herrmann, Caroline Imbert, Laurent Gorvel, Norbert Vey, Antoine Briantais, Anne Floch, Daniel Olive - Cell Reports 2021 cited by 92

  16. CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

    Authors: Julien Fourcade, Zhaojun Sun, Ornella Pagliano, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Daniel Olive, Vijay K. Kuchroo, Hassane M. Zarour - Cancer Research 2011 cited by 366

  17. PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

    Authors: Cécile Badoual, Stéphane Hans, Nathalie Merillon, Cordélia Van Ryswick, Patrice Ravel, Nadine Benhamouda, Émeline Levionnois, Mevyn Nizard, Ali Si‐Mohamed, Nicolas Besnier, Alain Gey, Rinat Rotem‐Yehudar, Hélène Péré, Thi Tran, Coralie L. Guérin, Anne Chauvat, Estelle Dransart, Cécile Alanio, Sébastien Albert, B. Barry, Federico Sandoval, Françoise Quintin‐Colonna, Patrick Bruneval, Wolf H. Fridman, François M. Lemoine, Stéphane Oudard, Ludger Johannes, Daniel Olive, Daniel Brasnu, Éric Tartour - Cancer Research 2012 cited by 634

  18. Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction

    Authors: Cyril Fauriat, Sylvaine Just‐Landi, Françoise Mallet, Christine Arnoulet, Danielle Sainty, Daniel Olive, Régis Costello - Blood 2006 cited by 370

  19. Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy

    Authors: F. Amatore, Laurent Gorvel, Daniel Olive - Expert Opinion on Biological Therapy 2019 cited by 128

  20. ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells

    Authors: Julien Faget, Nathalie Bendriss‐Vermare, Michael Gobert, Isabelle Durand, Daniel Olive, Cathy Biota, Thomas Bachelot, Isabelle Treilleux, Sophie Goddard‐Léon, Emilie Lavergne, Sylvie Chabaud, Jean‐Yves Blay, Christophe Caux, Christine Ménétrier‐Caux - Cancer Research 2012 cited by 210

  21. BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer

    Authors: Clémence Demerle, Laurent Gorvel, Daniel Olive - Frontiers in Oncology 2021 cited by 62

  22. Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation

    Authors: Laurent Gorvel, Daniel Olive - Seminars in Immunology 2022 cited by 40

  23. CpG Methylation Controls Reactivation of HIV from Latency

    Authors: Jana Blažková, Kateřina Trejbalová, Françoise Gondois‐Rey, Philippe Halfon, Philibert Patrick, Allan Guiguen, Eric Verdin, Daniel Olive, Carine Van Lint, Jiřı́ Hejnar, Ivan Hirsch - PLoS Pathogens 2009 cited by 327

  24. Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia

    Authors: Régis Costello, Simona Sivori, Emanuela Marcenaro, Mårina Lafage‐Pochitaloff, Julien Mozziconacci, D Reviron, Jean‐Albert Gastaut, Daniela Pende, Daniel Olive, Alessandro Moretta - Blood 2002 cited by 492